期刊文献+

小儿肝母细胞瘤的诊断和外科治疗 被引量:2

Diagnosis and surgical treatment of hepatoblastoma in childhood
原文传递
导出
摘要 目的总结小儿肝母细胞瘤诊治经验,探讨影响预后因素。方法回顾性分析1992年1月至2005年1月经手术、病理证实的29例肝母细胞瘤的临床资料。结果29例中TNMⅠ期8例、Ⅱ期14例、Ⅲ期6例、Ⅳ期1例;病理学类型有胎儿型18例,胚胎型5例,未分化型3例,混合型3例;行根治性切除25例(86%),姑息性切除4例(14%),并发症发生率13.7%(4/29),术后肝功能10d恢复正常。22例获随访,1、3、4年累积存活率分别为86.4%(n=19)、68.2%(n=15)、36.4%(n=8)。结论手术切除是小儿肝母细胞瘤首选的治疗方法,影响其预后的主要因素是临床分期和肿瘤组织分化程度、病理学类型。 Objective To investigate the diagnosis experience,effects of Surgical treatment and prognosis of hepatoblastoma (HB) in childhood. Methods The clinicopathological and follow-up data in 29 cases treated by hepatectomy from Jan 1992 to Jan 2005 were analyzed retrospectively. Results A retrospective analysis was made on 29 cases of TNM/s stage. There were 8 cases of stage Ⅰ , 14 cases of stage Ⅱ,6 cases of stage Ⅲ and 1 case of stage Ⅳ. 25 (86%) cases underwent radical resection,4 ( 14% ) cases of palliative resection. The overall postoperative complication rate was 13.7% (4/29). The liver function was recovered within 10 d; Twenty-two patients were followed-up. The overall 1-, 3-, 4-year survival were 19,15 and 8 cases, with survival rate of 86. 4%, 68. 2% and 36.4%. Conclusion Radical resection should be the first recommended treatment for hepatoblastoma in childhood. The clinical stage, differentiation and pathological type of the tumor impact prognosis significantly.
出处 《中国实用外科杂志》 CSCD 北大核心 2007年第2期150-151,共2页 Chinese Journal of Practical Surgery
关键词 肝母细胞瘤 肝切除术 Hepatoblastoma Hepatectomy
  • 相关文献

参考文献5

二级参考文献1

共引文献78

同被引文献22

  • 1高红,杨屹,漆衡,张可仞,王维林.巢式PCR法检测肝母细胞瘤中p15和p16基因启动子异常甲基化[J].中国当代儿科杂志,2005,7(5):404-407. 被引量:3
  • 2王甘露,李晓平,廖彩仙.肝母细胞瘤的诊断与治疗[J].临床和实验医学杂志,2006,5(6):707-708. 被引量:9
  • 3Roebuck D J, Perilongo G. Hepatoblastoma: an oncological review [J]. Pediatr Radiol, 2006, 36(3) :183-186.
  • 4Warmann SW, Fuchs J. Drug resistance in hepatoblastoma [ J ]. Curr Pharm Biotechnol, 2007, 8(2) :93-97.
  • 5Malogolowkin MH, Katzenstein HM, Krailo M, Chen Z, Quinn JJ, Reynolds M, et al. Redefining the role of doxorubiein for the treatment of children with hepatoblastoma [ J ]. J Clin Oncol, 2008, 26(14) :2379-2383.
  • 6Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, et al. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma[ J]. J Clin Oncol, 2006, 24 (18) :2879- 2884.
  • 7Blouin P, Brugieres L, Tabone MD, Leverger G, Rubie H, Branchereau S, et al. Carboplatin-epirubicin regimen for the treatment of hepatoblastoma[ J ]. Pediatr Blood Cancer, 2004, 42 ( 2 ) : 149- 154.
  • 8Suita S, Tajiri T, Takamatsu H, Mizote H, Nagasaki A, Inomata Y, et al. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen-a report from the study group for pediatric solid malignant tumors in the Kyushu area[ J]. J Pediatr Surg, 2004, 39(2):195-198.
  • 9陈嘉波,杨体泉,陈超,罗意革,唐咸明,董淳强.儿童肝细胞肝癌与肝母细胞瘤的临床特点及预后[J].实用儿科临床杂志,2007,22(15):1147-1148. 被引量:8
  • 10曾勇,林金容,练雄珍.小儿最常见的肝脏恶性肿瘤-肝母细胞瘤的研究现状[J].现代肿瘤医学,2008,16(3):490-492. 被引量:7

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部